文献速递骨质疏松与代谢性骨病

慢性肾脏病相关骨质疏松与糖尿病肾病患者新发衰弱相关:一项倾向性评分匹配队列研究

Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.
PubMed 文献 · Osteoporos Int · 2020-02-27

本研究基于台湾糖尿病患者纵向队列,纳入12,027例糖尿病肾病合并骨质疏松患者和24,054例倾向性评分匹配的对照,随访3.5±2.2年。结果显示合并骨质疏松的糖尿病肾病患者衰弱发生率更高(6.6 vs. 5.7/1000人年,p=0.04),校正混杂因素后衰弱风险显著增加(HR=1.19,95%CI 1.02–1.38)。

要点

  • 糖尿病肾病患者中,基线骨质疏松与随访期间新发衰弱风险独立相关。
  • 合并骨质疏松的糖尿病肾病患者衰弱发生率为6.6/1000人年,高于无骨质疏松者的5.7/1000人年。
  • 校正年龄、性别、肥胖、合并症及用药后,骨质疏松组衰弱风险仍显著升高(HR=1.19)。

核心结论

  • 在糖尿病肾病患者中,慢性肾脏病相关骨质疏松与更高的新发衰弱风险相关。

研究设计与样本

  • 基于台湾糖尿病患者纵向队列(n=840,000),识别12,027例合并骨质疏松的糖尿病肾病患者和24,054例倾向性评分匹配的无骨质疏松对照,前瞻性随访至终点或研究结束。

主要发现

  • 糖尿病肾病患者平均年龄67.2岁,女性占55.4%,基线骨质疏松患病率12.6%。
  • 随访3.5±2.2年后,合并骨质疏松的糖尿病肾病患者衰弱发生率为6.6/1000人年,无骨质疏松者为5.7/1000人年(p=0.04)。
  • 校正年龄、性别、肥胖、合并症和药物后,合并骨质疏松的糖尿病肾病患者新发衰弱风险显著更高(HR=1.19,95%CI 1.02–1.38)。

临床怎么用

  • 对糖尿病肾病患者应关注基线骨质疏松状况,并将其视为后续衰弱风险的潜在预警因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Chronic kidney disease (CKD)-related osteoporosis is a major complication in patients with CKD, conferring a higher risk of adverse outcomes. We found that among those with diabetic kidney disease, this complication increased the risk of incident frailty, an important mediator of adverse outcomes. INTRODUCTION: Renal osteodystrophy and chronic kidney disease (CKD)-related osteoporosis increases complications for patients with diabetic kidney disease (DKD). Since musculoskeletal degeneration is central to frailty development, we investigated the relationship between baseline osteoporosis and the subsequent frailty risk in patients with DKD. METHODS: From the Longitudinal Cohort of Diabetes Patients in Taiwan (n = 840,000), we identified 12,027 patients having DKD with osteoporosis and 24,054 propensity score-matched controls having DKD but without osteoporosis. The primary endpoint was incident frailty on the basis of a modified FRAIL scale. Patients were prospectively followed-up until the development of endpoints or the end of this study. The Kaplan-Meier technique and Cox proportional hazard regression were used to analyze the association between osteoporosis at baseline and incident frailty in these patients. RESULTS: The mean age of the DKD patients was 67.2 years, with 55.4% female and a 12.6% prevalence of osteoporosis at baseline. After 3.5 ± 2.2 years of follow up, the incidence rate of frailty in patients having DKD with osteoporosis was higher than that in DKD patients without (6.6 vs. 5.7 per 1000 patient-year, p = 0.04). A Cox proportional hazard regression showed that after accounting for age, gender, obesity, comorbidities, and medications, patients having DKD with osteoporosis had a significantly higher risk of developing frailty (hazard ratio, 1.19; 95% confidence interval, 1.02-1.38) than those without osteoporosis. CONCLUSIONS: CKD-related osteoporosis is associated with a higher risk of incident frailty in patients with DKD.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Chao CT, Wang J, Huang JW, et al. Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study. Osteoporos Int. 2020. PMID: 32103279. doi:10.1007/s00198-020-05353-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。